摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(2-(6-(tert-butoxy carbonylamino)hexylamino)-2-oxoethyl)-2-oxo-2H-chromen-7-yloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate | 1255535-20-6

中文名称
——
中文别名
——
英文名称
(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(2-(6-(tert-butoxy carbonylamino)hexylamino)-2-oxoethyl)-2-oxo-2H-chromen-7-yloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
英文别名
[(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[4-[2-[6-[(2-methylpropan-2-yl)oxycarbonylamino]hexylamino]-2-oxoethyl]-2-oxochromen-7-yl]oxyoxan-2-yl]methyl acetate
(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(2-(6-(tert-butoxy carbonylamino)hexylamino)-2-oxoethyl)-2-oxo-2H-chromen-7-yloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate化学式
CAS
1255535-20-6
化学式
C36H48N2O15
mdl
——
分子量
748.782
InChiKey
CBPPRFAJSINEJX-DDAJPSLKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    53
  • 可旋转键数:
    22
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    217
  • 氢给体数:
    2
  • 氢受体数:
    15

反应信息

  • 作为反应物:
    描述:
    (2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(2-(6-(tert-butoxy carbonylamino)hexylamino)-2-oxoethyl)-2-oxo-2H-chromen-7-yloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate甲醇sodium methylate 作用下, 反应 1.5h, 以65%的产率得到tert-butyl 6-(2-(2-oxo-7-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2H-chromen-4-yl)acetamido)hexylcarbamate
    参考文献:
    名称:
    Design and synthesis of substrates for newborn screening of Maroteaux–Lamy and Morquio A syndromes
    摘要:
    In continued efforts to develop enzymatic assays for lysosomal storage diseases appropriate for newborn screening laboratories we have synthesized novel and specific enzyme substrates for Maroteaux-Lamy (MPS VI) and Morquio A (MPS IVA) diseases. The sulfated monosaccharide derivatives were found to be converted to product by the respective enzyme in blood from healthy patients but not by blood from patients with the relevant lysosomal storage disease. The latter result shows that the designed substrates are highly selective for the respective enzymes. (c) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.08.080
  • 作为产物:
    描述:
    tert-butyl 6-(2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetamido)hexylcarbamate2,3,4,6-四乙酰氧基-alpha-D-吡喃糖溴化物四丁基硫酸氢铵 、 sodium hydroxide 作用下, 以 二氯甲烷 为溶剂, 反应 0.83h, 以1.4 g的产率得到(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-(2-(6-(tert-butoxy carbonylamino)hexylamino)-2-oxoethyl)-2-oxo-2H-chromen-7-yloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
    参考文献:
    名称:
    Design and synthesis of substrates for newborn screening of Maroteaux–Lamy and Morquio A syndromes
    摘要:
    In continued efforts to develop enzymatic assays for lysosomal storage diseases appropriate for newborn screening laboratories we have synthesized novel and specific enzyme substrates for Maroteaux-Lamy (MPS VI) and Morquio A (MPS IVA) diseases. The sulfated monosaccharide derivatives were found to be converted to product by the respective enzyme in blood from healthy patients but not by blood from patients with the relevant lysosomal storage disease. The latter result shows that the designed substrates are highly selective for the respective enzymes. (c) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.08.080
点击查看最新优质反应信息